The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
4-Methylumbelliferone Treatment and Hyaluronan Inhibition as a Therapeutic Strategy in Inflammation, Autoimmunity, and Cancer
Open accessAbstract
Hyaluronan (HA) is a prominent component of the extracellular matrix at many sites of chronic inflammation, including type 1 diabetes (T1D), multiple sclerosis, and numerous malignancies. Recent publications have demonstrated that when HA synthesis is inhibited using 4-methylumbelliferone (4-MU), beneficial effects are observed in several animal models of these diseases. Notably, 4-MU is an already approved drug in Europe and Asia called "hymecromone" where it is used to treat biliary spasm. However, there is uncertainty regarding how 4-MU treatment provides benefit in these animal models and the potential long-term consequences of HA inhibition. Here, we review what is known about how HA contributes to immune dysregulation and tumor progression. Then, we review what is known about 4-MU and hymecromone in terms of mechanism of action, pharmacokinetics, and safety. Finally, we review recent studies detailing the use of 4-MU to treat animal models of cancer and autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T. (2008) · Nature · doi:10.1038/nature07039 · Cited by 6,542
Fitzgerald, M., Hayward, I. P., Thomas, A. C., Campbell, J. H., & CAMPBELL, G. R. (1995) · Cited by 2,552
FOXP3+ regulatory T cells in the human immune system
Sakaguchi, S., Miyara, M., Costantino, C. M., & Hafler, D. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2785 · Cited by 2,439
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
Regulation of lung injury and repair by Toll-like receptors and hyaluronan
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1315 · Cited by 1,401
Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4
Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., & Simon, J. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20001858 · Cited by 1,378
Hyaluronan fragments: An information-rich system
Stern, R., Asari, A. A., & Sugahara, K. N. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2006.05.009 · Cited by 1,132
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Jacobetz, M. A., Chan, D. S., Neesse, A., Bapiro, T. E., Cook, N., Frese, K. K., Feig, C., Nakagawa, T., Caldwell, M. E., Zecchini, H. I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302529 · Cited by 1,120
Hyaluronan as an Immune Regulator in Human Diseases
Jiang, D., Liang, J., & Noble, P. W. (2011) · Physiological Reviews · doi:10.1152/physrev.00052.2009 · Cited by 1,060
Signaling Properties of Hyaluronan Receptors
Turley, E. A., Noble, P. W., & Bourguignon, L. Y. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100038200 · Cited by 1,041
Hyaluronan in Tissue Injury and Repair
Jiang, D., Liang, J., & Noble, P. W. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123337 · Cited by 835
The tumour microenvironment as a target for chemoprevention
Albini, A., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2067 · Cited by 823
McKee, C. M., Penno, M. B., Cowman, M., Burdick, M. D., Strieter, R. M., Bao, C., & Noble, P. W. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119054 · Cited by 806
Hyaluronidases: Their Genomics, Structures, and Mechanisms of Action
Stern, R., & Jedrzejas, M. J. (2006) · Chemical Reviews · doi:10.1021/cr050247k · Cited by 804
High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat
Tian, X., Azpurua, J., Hine, C., Vaidya, A., Myakishev-Rempel, M., Ablaeva, J., Mao, Z., Nevo, E., Gorbunova, V., & Seluanov, A. (2013) · Nature · doi:10.1038/nature12234 · Cited by 784
Toll-like receptor 2 controls expansion and function of regulatory T cells
Sutmuller, R. P. M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25439 · Cited by 756
The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification
Rowland, A., Miners, J. O., & Mackenzie, P. I. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.019 · Cited by 709
Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR2
Scheibner, K. A., Lutz, M. A., Boodoo, S., Fenton, M. J., Powell, J. D., & Horton, M. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1272 · Cited by 708 · cited 1×
“LMW-HA promotes the activation and maturation of dendritic cells (DCs) (34), drives the release of pro-inflammatory cytokines such as IL-1β, TNF-α, IL-6, and IL-12 by multiple cell types (35–39), drives chemokine expression and cell trafficking (40, 41), and promotes proliferation (42, 43) and angiogenesis (44).”
BackgroundChoi, H., Lee, R. H., Bazhanov, N., Oh, J. Y., & Prockop, D. J. (2011) · Blood · doi:10.1182/blood-2010-12-327353 · Cited by 637
Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation
Back, S. A., Tuohy, T. M. F., Chen, H., Wallingford, N., Craig, A., Struve, J., Luo, N. L., Banine, F., Liu, Y., Chang, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1279 · Cited by 612 · cited 4×
“It is produced by local astrocytes (63, 64), and is known to contribute to EAE by promoting the extravasation of leukocytes (65) and inhibiting oligodendrocyte maturation (66, 67).”
BackgroundInfluentialHyaluronan-binding Proteins: Tying Up the Giant
Day, A. J., & Prestwich, G. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100036200 · Cited by 567
Hyaluronan: a multifunctional, megaDalton, stealth molecule
Lee, J. Y., & Spicer, A. P. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00135-6 · Cited by 525
The structure and function of hyaluronan: An overview
LAURENT, T. C., LAURENT, U. B., & FRASER, J. R. E. (1996) · Immunology & Cell Biology · doi:10.1038/icb.1996.32 · Cited by 503
Hyaluronan-Cell Interactions in Cancer and Vascular Disease
Toole, B. P., Wight, T. N., & Tammi, M. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100039200 · Cited by 491
Self-citationHA receptors: Regulators of signalling to the cytoskeleton
Entwistle, J., Hall, C. L., & Turley, E. A. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960616)61:4<569::aid-jcb10>3.0.co;2-b · Cited by 472
Slevin, M., Krupinski, J., Gaffney, J., Matou, S., West, D., Delisser, H., Savani, R. C., & Kumar, S. (2007) · Matrix Biology · doi:10.1016/j.matbio.2006.08.261 · Cited by 432
Supramolecular organization of extracellular matrix glycosaminoglycans, in vitro and in the tissues
Scott, J. E. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.9.1612287 · Cited by 383
Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2
Sloane, J. A., Batt, C., Ma, Y., Harris, Z. M., Trapp, B., & Vartanian, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006496107 · Cited by 360
Uchaipichat, V., Mackenzie, P. I., Guo, X.-H., Gardner-Stephen, D., Galetin, A., Houston, J. B., & Miners, J. O. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.4.413 · Cited by 335
Hyaluronan cross-linking: a protective mechanism in inflammation?
Day, A. J., & de la Motte, C. A. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.09.009 · Cited by 334
Interaction of tumor cells with the microenvironment
Ungefroren, H., Sebens, S., Seidl, D., Lehnert, H., & Hass, R. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-18 · Cited by 333
Fraser, J. R. F., Laurent, T. C., Pertoft, H., & Baxter, E. (1981) · Biochemical Journal · doi:10.1042/bj2000415 · Cited by 332
Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer
Provenzano, P. P., & Hingorani, S. R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.569 · Cited by 323
Inhibition of phagocytosis by high molecular weight hyaluronate.
Forrester, J. V., & Balazs, E. A. (1980) · PubMed · Cited by 303
Itano, N., Atsumi, F., Sawai, T., Yamada, Y., Miyaishi, O., Senga, T., Hamaguchi, M., & Kimata, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052026799 · Cited by 298
Hyaluronan in human malignancies
Sironen, R. K., Tammi, M., Tammi, R., Auvinen, P. K., Anttila, M., & Kosma, V.-M. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.11.017 · Cited by 294
Brocke, S., Piercy, C., Steinman, L., Weissman, I. L., & Veromaa, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6896 · Cited by 282
Kultti, A., Pasonen-Seppänen, S., Jauhiainen, M., Rilla, K. J., Kärnä, R., Pyöriä, E., Tammi, R. H., & Tammi, M. I. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.03.002 · Cited by 280
A Novel Mechanism for the Inhibition of Hyaluronan Biosynthesis by 4-Methylumbelliferone
Kakizaki, I., Kojima, K., Takagaki, K., Endo, M., Kannagi, R., Ito, M., Maruo, Y., Sato, H., Yasuda, T., Mita, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405918200 · Cited by 277
The role of hyaluronan in tumour neovascularization (review)
Rooney, P., Kumar, S., Ponting, J., & Wang, M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600511 · Cited by 271
Intracellular hyaluronan: a new frontier for inflammation?
HASCALL, V (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.02.013 · Cited by 246
Hiraga, T., Ito, S., & Nakamura, H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3801 · Cited by 226
Okuda, H., Kobayashi, A., Xia, B., Watabe, M., Pai, S. K., Hirota, S., Xing, F., Liu, W., Pandey, P. R., Fukuda, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1678 · Cited by 201
Ruppert, S. M., Hawn, T. R., Arrigoni, A., Wight, T. N., & Bollyky, P. L. (2014) · Immunologic Research · doi:10.1007/s12026-014-8495-2 · Cited by 197
Self-citationThe Role of Hyaluronan Degradation Products as Innate Alloimmune Agonists
Tesar, B. M., Jiang, D., Liang, J., Palmer, S. M., Noble, P. W., & Goldstein, D. R. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01537.x · Cited by 196
Role of CD44 and Hyaluronan in Neutrophil Recruitment
Khan, A. I., Kerfoot, S. M., Heit, B., Liu, L., Andonegui, G., Ruffell, B., Johnson, P., & Kubes, P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7594 · Cited by 195
Neumann, A., Schinzel, R., Palm, D., Riederer, P., & Münch, G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00731-0 · Cited by 195
Lokeshwar, V. B., Lopez, L. E., Munoz, D., Chi, A., Shirodkar, S. P., Lokeshwar, S. D., Escudero, D. O., Dhir, N., & Altman, N. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3185 · Cited by 191
Gao, F., Koenitzer, J. R., Tobolewski, J. M., Jiang, D., Liang, J., Noble, P. W., & Oury, T. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709273200 · Cited by 186
Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis
Gao, F., Liu, Y., He, Y., Yang, C., Wang, Y., Shi, X., & Wei, G. (2010) · Matrix Biology · doi:10.1016/j.matbio.2009.11.002 · Cited by 185
Howlett, A. R., & Bissell, M. J. (1993) · PubMed · Cited by 185
Serum Hyaluronan as a Disease Marker
Laurent, T. C., Laurent, U. B. G., & Fraser, J. R. E. (1996) · Annals of Medicine · doi:10.3109/07853899609033126 · Cited by 175
Bollyky, P. L., Lord, J. D., Masewicz, S. A., Evanko, S. P., Buckner, J. H., Wight, T. N., & Nepom, G. T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.744 · Cited by 173
Self-citationHyaluronan and versican in the control of human T-lymphocyte adhesion and migration
Evanko, S. P., Potter‐Perigo, S., Bollyky, P. L., Nepom, G. T., & Wight, T. N. (2011) · Matrix Biology · doi:10.1016/j.matbio.2011.10.004 · Cited by 170
Self-citationCampo, G. M., Avenoso, A., Campo, S., D’Ascola, A., Nastasi, G., & Calatroni, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.024 · Cited by 166
Pharmacogenomics of Human Uridine Diphospho-Glucuronosyltransferases and Clinical Implications
Guillemette, C., Lévesque, É., & Rouleau, M. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.126 · Cited by 163
Kota, D. J., Wiggins, L. L., Yoon, N., & Lee, R. H. (2013) · Diabetes · doi:10.2337/db12-0931 · Cited by 162
Li, Y., Li, L., Brown, T. J., & Heldin, P. (2007) · International Journal of Cancer · doi:10.1002/ijc.22550 · Cited by 158
Regulation of Hyaluronan-Induced Chemokine Gene Expression by IL-10 and IFN-γ in Mouse Macrophages
Horton, M. R., Burdick, M. D., Strieter, R. M., Bao, C., & Noble, P. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.3023 · Cited by 157
Campo, G. M., Avenoso, A., Nastasi, G., Micali, A. G., Prestipino, V., Vaccaro, M., D’Ascola, A., Calatroni, A., & Campo, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.006 · Cited by 156
Inhibition of Hyaluronan Synthesis Accelerates Murine Atherosclerosis
Nagy, N., Freudenberger, T., Melchior‐Becker, A., Roeck, K., ter Braak, M., Jastrow, H., Kinzig, M., Lucke, S., Suvorava, T., Kojda, G., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.972653 · Cited by 153
Self-citationBourguignon, L., Gilad, E., & Peyrollier, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610054200 · Cited by 152
Bollyky, P. L., Wu, R. P., Falk, B. A., Lord, J. D., Long, S. A., Preisinger, A., Teng, B. J., Holt, G. E., Standifer, N. E., Braun, K. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017360108 · Cited by 145
Self-citationUrakawa, H., Nishida, Y., Wasa, J., Arai, E., Zhuo, L., Kimata, K., Kozawa, E., Futamura, N., & Ishiguro, N. (2011) · International Journal of Cancer · doi:10.1002/ijc.26014 · Cited by 144
Threat matrix: Low-molecular-weight hyaluronan (HA) as a danger signal
Powell, J. D., & Horton, M. R. (2005) · Immunologic Research · doi:10.1385/ir:31:3:207 · Cited by 142
Horton, M. R., Burdick, M., Strieter, R. M., Bao, C., & Noble, P. W. (1998) · PubMed · Cited by 141
Struve, J. N., Maher, P. C., Li, Y., Kinney, S. D., Fehlings, M. G., Kuntz, C., & Sherman, L. S. (2005) · Glia · doi:10.1002/glia.20215 · Cited by 141
Extracellular Matrix Components in the Pathogenesis of Type 1 Diabetes
Bogdani, M., Korpos, É., Simeonovic, C. J., Parish, C. R., Sorokin, L. M., & Wight, T. N. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0552-7 · Cited by 141
Self-citationde la Motte, C., Nigro, J., Vasanji, A., Rho, H. K., Kessler, S. P., Bandyopadhyay, S. K., Danese, S., Fiocchi, C., & Stern, R. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080831 · Cited by 138
Hyaluronan Accumulates With High-Fat Feeding and Contributes to Insulin Resistance
Kang, L., Lantier, L., Kennedy, A., Bonner, J. S., Mayes, W. H., Bracy, D. P., Bookbinder, L. H., Hasty, A. H., Thompson, C. B., & Wasserman, D. H. (2013) · Diabetes · doi:10.2337/db12-1502 · Cited by 133 · cited 1×
“HA IN CHRONIC INFLAMMATION Many chronic disease processes associated with unremitting inflammation are associated with prolonged increases in HA, including type 2 diabetes (T2D) (46, 47), liver cirrhosis (48), asthma, and other diseases (49–54).”
BackgroundAuvinen, P., Rilla, K. J., Tumelius, R., Tammi, M., Sironen, R. K., Soini, Y., Kosma, V., Mannermaa, A., Viikari, J., & Tammi, R. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2804-7 · Cited by 132
A hyaluronan synthase suppressor, 4‐methylumbelliferone, inhibits liver metastasis of melanoma cells
Yoshihara, S., Kon, A., Kudo, D., Nakazawa, H., Kakizaki, I., Sasaki, M., Endo, M., & Takagaki, K. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.079 · Cited by 129
Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection
Wong, V. S., Hughes, V. F., Trull, A. K., Wight, D. G. D., Petrík, J., & Alexander, G. (1998) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1998.00100.x · Cited by 127
Weiss, L., Slavin, S., Reich, S., Cohen, P., Shuster, S., Stern, R., Kaganovsky, E., Okon, E., Rubinstein, A. M., & Naor, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.285 · Cited by 125
Baumgartner, G., Gomar-Höss, C., Sakr, L., Ulsperger, E., & Wogritsch, C. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00204-3 · Cited by 123
Bogdani, M., Johnson, P. Y., Potter‐Perigo, S., Nagy, N., Day, A. J., Bollyky, P. L., & Wight, T. N. (2014) · Diabetes · doi:10.2337/db13-1658 · Cited by 123
Self-citationVigetti, D., Ori, M., Viola, M., Genasetti, A., Karousou, E., Rizzi, M., Pallotti, F., Nardi, I., Hascall, V. C., Luca, G. D., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508516200 · Cited by 120
Asher, R., Perides, G., Vanderhaeghen, J., & Bignami, A. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490280314 · Cited by 119
Regulation of Colonic Epithelial Repair in Mice by Toll-Like Receptors and Hyaluronic Acid
Zheng, L., Riehl, T. E., & Stenson, W. F. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.055 · Cited by 118
Bhattacharyya, S. S., Paul, S., Mandal, S. K., Banerjee, A., Boujedaini, N., & Khuda‐Bukhsh, A. R. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.015 · Cited by 118
Toole, B. P., & Hascall, V. C. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64232-0 · Cited by 117
Jong, A., Wu, C.-H., Chen, H.-M., Luo, F., Kwon-Chung, K. J., Chang, Y. C., LaMunyon, C. W., Plaas, A., & Huang, S.-H. (2007) · Eukaryotic Cell · doi:10.1128/ec.00120-07 · Cited by 113
The selective suppression of immunogenicity by hyaluronic acid.
Delmage, J. M., Powars, D., Jaynes, P. K., & Allerton, S. E. (1986) · PubMed · Cited by 113
Simpson, M. A., Reiland, J., Burger, S. R., Furcht, L. T., Spicer, A. P., Oegema, T. R., & McCarthy, J. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010064200 · Cited by 109
Role of hyaluronan and hyaluronan-binding proteins in human asthma
Liang, J., Jiang, D., Jung, Y., Xie, T., Ingram, J. L., Church, T. D., Degan, S., Leonard, M., Kraft, M., & Noble, P. W. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.04.006 · Cited by 105
Bugiani, M., Postma, N. L., Polder, E., Dieleman, N., Scheffer, P. G., Sim, F. J., van der Knaap, M. S., & Boor, I. (2013) · Brain · doi:10.1093/brain/aws320 · Cited by 105
Piccioni, F., Malvicini, M., García, M. G., Rodriguez, A., Atorrasagasti, C., Kippes, N., Buena, I. T. P., Rizzo, M., Bayo, J., Aquino, J. B., et al. (2011) · Glycobiology · doi:10.1093/glycob/cwr158 · Cited by 103
Vigetti, D., Rizzi, M., Viola, M., Karousou, E. G., Genasetti, A., Clerici, M., Bartolini, B., Hascall, V. C., Luca, G. D., & Passi, A. G. (2009) · Glycobiology · doi:10.1093/glycob/cwp022 · Cited by 102
The Role of Hyaluronan and the Extracellular Matrix in Islet Inflammation and Immune Regulation
Bollyky, P. L., Bogdani, M., Bollyky, J., Hull, R. L., & Wight, T. N. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0297-0 · Cited by 100
Self-citationAstrocytes in aged nonhuman primate brain gray matter synthesize excess hyaluronan
Cargill, R. S., Kohama, S. G., Struve, J. N., Su, W., Banine, F., Witkowski, E. D., Back, S. A., & Sherman, L. S. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.07.006 · Cited by 96
Forteza, R., Casalino‐Matsuda, S. M., Falcon, N. S., Gattas, M. V., & Monzon, M. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.387795 · Cited by 92
Irving‐Rodgers, H. F., Ziolkowski, A., Parish, C. R., Sado, Y., Ninomiya, Y., Simeonovic, C. J., & Rodgers, R. J. (2008) · Diabetologia · doi:10.1007/s00125-008-1085-x · Cited by 92
Rilla, K. J., Pasonen‐Seppänen, S., Rieppo, J., Tammi, M., & Tammi, R. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23409.x · Cited by 88
Guan, H., Nagarkatti, P. S., & Nagarkatti, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802325 · Cited by 86
Arai, E., Nishida, Y., Wasa, J., Urakawa, H., Zhuo, L., Kimata, K., Kozawa, E., Futamura, N., & Ishiguro, N. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.459 · Cited by 86
Hyaluronan in intestinal homeostasis and inflammation: implications for fibrosis
de la Motte, C. A. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00063.2011 · Cited by 84
High molecular weight hyaluronan reduces lipopolysaccharide mediated microglial activation
Austin, J. W., Gilchrist, C., & Fehlings, M. G. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07789.x · Cited by 82
Hyaluronan deposition and correlation with inflammation in a murine ovalbumin model of asthma
Cheng, G., Swaidani, S., Sharma, M., Lauer, M. E., Hascall, V. C., & Aronica, M. A. (2011) · Matrix Biology · doi:10.1016/j.matbio.2010.12.003 · Cited by 82
Wilkinson, T. S., Bressler, S. L., Evanko, S. P., Braun, K. R., & Wight, T. N. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20468 · Cited by 79
Self-citationBullard, K. M., Kim, H., Wheeler, M. A., Wilson, C. M., Neudauer, C. L., Simpson, M. A., & McCarthy, J. B. (2003) · International Journal of Cancer · doi:10.1002/ijc.11475 · Cited by 78
Yoshioka, Y., Kozawa, E., Urakawa, H., Arai, E., Futamura, N., Zhuo, L., Kimata, K., Ishiguro, N., & Nishida, Y. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37861 · Cited by 74
Hyaluronan receptors involved in cytokine induction in monocytes
Yamawaki, H., Hirohata, S., Miyoshi, T., Takahashi, K., Ogawa, H., Shinohata, R., Demircan, K., Kusachi, S., Yamamoto, K., & Ninomiya, Y. (2008) · Glycobiology · doi:10.1093/glycob/cwn109 · Cited by 72
Twarock, S., Freudenberger, T., Poscher, E. R. G., Dai, G., Jannasch, K., Dullin, C., Alves, F., Prenzel, K., Knoefel, W. T., Stoecklein, N. H., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-30 · Cited by 70
Bollyky, P. L., Evanko, S. P., Wu, R. P., Potter‐Perigo, S., Long, S. A., Kinsella, B., Reijonen, H., Guebtner, K., Teng, B. J., Chan, C. K., et al. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.9 · Cited by 66
Self-citationGaleano, M., Polito, F., Bitto, A., Irrera, N., Campo, G. M., Avenoso, A., Calò, M., Cascio, P. L., Minutoli, L., Barone, M., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.03.012 · Cited by 65
Hyaluronan minimizes effects of UV irradiation on human keratinocytes
Hašová, M., Crhák, T., Šafránková, B., Dvořáková, J., Muthný, T., Velebný, V., & Kubala, L. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-011-1146-8 · Cited by 63
Naor, D., Nedvetzki, S., Walmsley, M. J., Yayon, A., Turley, E. A., Golan, I., Caspi, D., Eshkar-Sebban, L., Zick, Y., Garin, T., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1423.025 · Cited by 61
Mueller, A. M., Yoon, B. H., & Sadiq, S. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559583 · Cited by 59
Gibbs, P., Clingan, P. R., Ganju, V., Strickland, A. H., Wong, S., Tebbutt, N. C., Underhill, C. R., Fox, R. M., Clavant, S. P., Leung, J., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1303-3 · Cited by 55
Human leukemic cell lines synthesize hyaluronan to avoid senescence and resist chemotherapy
Lompardía, S. L., Papademetrio, D. L., Mascaro, M., Alvarez, E. M. D. C., & HAJOS, S. E. (2013) · Glycobiology · doi:10.1093/glycob/cwt074 · Cited by 55
Morohashi, H., Yoshihara, S., Makoto, N., Yamaguchi, M., Kakizaki, I., Atsushi, K., Sasaki, M., & Takagaki, K. (2007) · International Journal of Cancer · doi:10.1002/ijc.22349 · Cited by 52
Kundu, B., Saha, P., Datta, K., & Kundu, S. C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.047 · Cited by 52
Winkler, C. W., Foster, S. C., Matsumoto, S. G., Preston, M., Xing, R., Bebo, B. F., Banine, F., Berny‐Lang, M. A., Itakura, A., McCarty, O. J. T., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356287 · Cited by 52
Ye, J., Wu, H., Wu, Y., Wang, C., Zhang, H., Shi, X., & Yang, J. J. (2012) · Eye · doi:10.1038/eye.2012.89 · Cited by 50
Sim, M., Ham, J. R., Lee, H.-I., Seo, K., & Lee, M. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.03.003 · Cited by 50
McKallip, R. J., Ban, H., & Uchakina, O. N. (2014) · Inflammation · doi:10.1007/s10753-014-0092-y · Cited by 47
Inhibition of hyaluronan synthesis in Streptococcus equi FM100 by 4‐methylumbelliferone
Kakizaki, I., Takagaki, K., Endo, Y., Kudo, D., Ikeya, H., Miyoshi, T., Baggenstoss, B. A., Tlapak‐Simmons, V. L., Kumari, K., Nakane, A., et al. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03217.x · Cited by 46
Edward, M., Quinn, J. A., Pasonen‐Seppänen, S., McCann, B. A., & Tammi, R. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09699.x · Cited by 46
Vigetti, D., Rizzi, M., Moretto, P., Deleonibus, S., Dreyfuss, J. M., Karousou, E. G., Viola, M., Clerici, M., Hascall, V. C., Ramoni, M. F., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.266312 · Cited by 46
Hyaluronan Synthesis Is Required for IL-2-Mediated T Cell Proliferation
Mahaffey, C. L., & Mummert, M. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8191 · Cited by 43
Serum Hyaluronan Concentration as a Marker of Angiopathy in Patients with Diabetes Mellitus
Mine, S., Okada, Y., Kawahara, C., Tabata, T., & Tanaka, Y. (2006) · Endocrine Journal · doi:10.1507/endocrj.k05-119 · Cited by 41
Hull, R. L., Johnson, P. Y., Braun, K. R., Day, A. J., & Wight, T. N. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412457048 · Cited by 41
Self-citationThe Development of Hyaluronan as a Drug Transporter and Excipient for Chemotherapeutic Drugs
Brown, T. J. (2008) · Current Pharmaceutical Biotechnology · doi:10.2174/138920108785161514 · Cited by 40
Sputum Hyaluronan and Versican in Severe Eosinophilic Asthma
Ayars, A. G., Altman, L. C., Potter‐Perigo, S., Radford, K., Wight, T. N., & Nair, P. K. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000343031 · Cited by 38
Self-citationGianoukakis, A. G., Jennings, T. A., King, C. S., Sheehan, C. E., Hoa, N. T., Heldin, P., & Smith, T. J. (2006) · Endocrinology · doi:10.1210/en.2006-0736 · Cited by 37
4-Methylumbelliferone leads to growth arrest and apoptosis in canine mammary tumor cells
Saito, T., Tamura, D., NAKAMURA, T., MAKITA, Y., ARIYAMA, H., KOMIYAMA, K., YOSHIHARA, T., & Asano, R. (2012) · Oncology Reports · doi:10.3892/or.2012.2100 · Cited by 36
Saito, T., Tamura, D., & Asano, R. (2013) · Oncology Letters · doi:10.3892/ol.2013.1124 · Cited by 36
Tamura, R., Yokoyama, Y., Yoshida, H., Imaizumi, T., & Mizunuma, H. (2014) · Journal of Ovarian Research · doi:10.1186/preaccept-4117485191398206 · Cited by 34
Tofuku, K., Yokouchi, M., Murayama, T., Minami, S., & Komiya, S. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.1.175 · Cited by 33
McKallip, R. J., Hagele, H., & Uchakina, O. N. (2013) · Toxins · doi:10.3390/toxins5101814 · Cited by 32
High MW hyaluronan inhibits smoke inhalation‐induced lung injury and improves survival
Huang, P., Syrkina, O. L., Yu, L., Dedaj, R., Zhao, H., Shiedlin, A., Liu, Y.-Y., Garg, H. G., Quinn, D. A., & Hales, C. A. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01829.x · Cited by 31
Uchakina, O. N., Ban, H., & McKallip, R. J. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.07.009 · Cited by 29
The Role of Hyaluronan and CD44 in the Pathogenesis of Lupus Nephritis
Yung, S., & Chan, T. M. (2012) · Autoimmune Diseases · doi:10.1155/2012/207190 · Cited by 28
The Detection of Glycosaminoglycans in Pancreatic Islets and Lymphoid Tissues
Bogdani, M., Simeonovic, C. J., Nagy, N., Johnson, P. Y., Chan, C. K., & Wight, T. N. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1714-3_32 · Cited by 14
Self-citationKarbownik, M. S., Pietras, T., Szemraj, J., Kowalczyk, E., & Nowak, J. Z. (2014) · Współczesna Onkologia · doi:10.5114/wo.2014.43493 · Cited by 7
Cited by
Hyaluronan: molecular size‐dependent signaling and biological functions in inflammation and cancer
Tavianatou, A. G., Caon, I., Franchi, M., Piperigkou, Z., Galesso, D., & Karamanos, N. K. (2019) · The FEBS Journal · doi:10.1111/febs.14777 · Cited by 462
Hyaluronan biology: A complex balancing act of structure, function, location and context
Garantziotis, S., & Savani, R. C. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.02.002 · Cited by 386
Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics
Karamanos, N. K., Piperigkou, Z., Theocharis, A. D., Watanabe, H., Franchi, M., Baud, S., Brézillon, S., Götte, M., Passi, A., Vigetti, D., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00354 · Cited by 367
Targeting ECM Disrupts Cancer Progression
Venning, F. A., Wullkopf, L., & Erler, J. T. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00224 · Cited by 254
Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis
Yang, Y. M., Noureddin, M., Liu, C., Ohashi, K., Kim, S. Y., Ramnath, D., Powell, E. E., Sweet, M. J., Roh, Y. S., Hsin, I.-F., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat9284 · Cited by 166
Metadata
- Authors
- Nagy, N., Kuipers, H. F., Frymoyer, A. R., Ishak, H. D., Bollyky, J. B., Wight, T. N., & Bollyky, P. L.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2015-03-23
- Volume
- 6
- Pages
- 123-123
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2035240370
- Cited by
- 280
- References
- 136
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.